Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 5,442,000 | 5,203,000 | 5,285,000 | 5,065,000 | 5,061,000 |
| Cost of Goods | 1,594,000 | 1,590,000 | 1,608,000 | 1,523,000 | 1,637,000 |
| Gross Profit | 3,848,000 | 3,614,000 | 3,678,000 | 3,542,000 | 3,424,000 |
| Operating Expenses | 2,670,000 | 2,514,000 | 2,853,000 | 2,495,000 | 2,605,000 |
| Operating Income | 1,178,000 | 1,101,000 | 825,000 | 1,048,000 | 819,000 |
| Interest Expense | 96,000 | 90,000 | 90,000 | 87,000 | 90,000 |
| Other Income | -22,000 | 151,000 | -35,000 | -22,000 | 212,000 |
| Pre-tax Income | 1,060,000 | 1,162,000 | 700,000 | 939,000 | 941,000 |
| Income Tax | 155,000 | -176,000 | 31,000 | 183,000 | 146,000 |
| Net Income Continuous | 905,000 | 1,338,000 | 669,000 | 756,000 | 795,000 |
| Minority Interests | -2,000 | -2,000 | -2,000 | N/A | -2,000 |
| Net Income | $907,000 | $1,341,000 | $672,000 | $755,000 | $797,000 |
| EPS Basic Total Ops | 0.62 | 0.90 | 0.45 | 0.51 | 0.54 |
| EPS Basic Continuous Ops | 0.62 | 0.90 | 0.45 | 0.51 | 0.54 |
| EPS Diluted Total Ops | 0.61 | 0.90 | 0.45 | 0.51 | 0.53 |
| EPS Diluted Continuous Ops | 0.61 | 0.90 | 0.45 | 0.51 | 0.53 |
| EPS Diluted Before Non-Recurring Items | 0.86 | 0.80 | 0.80 | 0.75 | 0.75 |
| EBITDA(a) | $1,533,000 | $1,450,000 | $1,189,000 | $1,389,000 | $1,201,000 |